Last updated: 4 April 2024 at 5:50pm EST

Patrick F Smith Net Worth




The estimated Net Worth of Patrick F Smith is at least 1.77 百万$ dollars as of 2 April 2024. Patrick Smith owns over 14,427 units of Certara stock worth over 549,999$ and over the last 3 years Patrick sold CERT stock worth over 1,220,379$.

Patrick Smith CERT stock SEC Form 4 insiders trading

Patrick has made over 9 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 14,427 units of CERT stock worth 243,095$ on 2 April 2024.

The largest trade Patrick's ever made was selling 19,104 units of Certara stock on 5 June 2023 worth over 411,691$. On average, Patrick trades about 7,451 units every 61 days since 2021. As of 2 April 2024 Patrick still owns at least 50,091 units of Certara stock.

You can see the complete history of Patrick Smith stock trades at the bottom of the page.



What's Patrick Smith's mailing address?

Patrick's mailing address filed with the SEC is C/O CERTARA, INC., 100 OVERLOOK CENTER, SUITE 101, PRINCETON, NJ, 08540.

Insiders trading at Certara

Over the last 5 years, insiders at Certara have traded over 2,048,278,243$ worth of Certara stock and bought 97,245 units worth 1,908,085$ . The most active insiders traders include Avatar Parent L.P.Eqt Avata...James E Iii CashmanMason P Slaine. On average, Certara executives and independent directors trade stock every 14 days with the average trade being worth of 7,828,136$. The most recent stock trade was executed by Leif E Pedersen on 9 September 2024, trading 51,224 units of CERT stock currently worth 578,319$.



What does Certara do?

Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.



What does Certara's logo look like?

Certara, Inc. logo

Complete history of Patrick Smith stock trades at Certara

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
2 Apr 2024 Patrick F Smith
社長、DRUG DEV SOLUTIONS
販売 14,427 16.85$ 243,095$
2 Apr 2024
50,091
1 Apr 2024 Patrick F Smith
社長、DRUG DEV SOLUTIONS
オプション行使 16,498 18.00$ 296,964$
1 Apr 2024
67,208
20 Feb 2024 Patrick F Smith
社長、DRUG DEV SOLUTIONS
販売 5,000 18.00$ 90,000$
20 Feb 2024
54,975
5 Jun 2023 Patrick F Smith
社長、DRUG DEV SOLUTIONS
販売 19,104 21.55$ 411,691$
5 Jun 2023
59,975
31 Mar 2023 Patrick F Smith
社長、DRUG DEV SOLUTIONS
オプション行使 8,646 24.11$ 208,455$
31 Mar 2023
81,973
9 Nov 2022 Patrick F Smith
社長、DRUG DEV SOLUTIONS
販売 2,387 13.48$ 32,177$
9 Nov 2022
74,859
16 Aug 2022 Patrick F Smith
社長、DRUG DEV SOLUTIONS
販売 10,000 17.71$ 177,100$
16 Aug 2022
78,490
8 Jun 2022 Patrick F Smith
社長、DRUG DEV SOLUTIONS
販売 10,000 19.16$ 191,600$
8 Jun 2022
88,490
1 Apr 2022 Patrick F Smith
社長、DRUG DEV SOLUTIONS
販売 3,352 22.29$ 74,716$
1 Apr 2022
98,490


Certara executives and stock owners

Certara executives and other stock owners filed with the SEC include: